Alibaba's counterfeits spat may signal e-commerce shift
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Alibaba's counterfeits spat may signal e-commerce shift

Criticisms from Chinese regulators directed at Alibaba may be part of a larger move to regulate e-commerce

Screenshot of Taobao page

Alibaba's Taobao, China's largest ecommerce site, features many products with luxury branding

On Wednesday, China's State Administration for Industry and Commerce (SAIC) released a white paper slamming Alibaba for a range of illegal practices relating to its online marketplaces.

The paper faulted the company for not taking sufficient steps to stop the sale of counterfeit goods on its platforms, including Taobao, its tremendously popular eBay-like shopping platform. The paper also accused the company of other misdeeds, including failing to ensure that sellers have appropriate registrations and licences, engaging in anti-competitive practices and not doing enough to clamp down on misleading seller practices such as fake transactions and reviews to boost rankings.

In response, Alibaba acknowledged that it needed to do more to combat problems. However, it also said that it disagreed with the findings and that it would file a complaint with the SAIC over what it claims to be procedural misconduct in the investigation.

A persistent problem

Criticisms of Alibaba from rights holders and international governments are nothing new. Taobao was listed as a notorious market by the United States Trade Representative until 2012, and even after it was taken off the list, the presence of counterfeits on the platform persisted. Since then, Alibaba has continued to work to improve its anti-counterfeiting efforts, including agreements to cooperate with brand owners such as Louis Vuitton Moet Hennessy, Microsoft and Keiring (the owner of brands including Gucci). The company has also continued to refine its takedown procedures, including the most recent changes to the TaoProtect system. Yet, despite some newsworthy gains and high-profile agreements to work with groups such as the China-Britain Business Council, representatives from several international companies have told Managing IP of their continuing dissatisfaction with Alibaba's efforts at protecting brands.

Not just about counterfeits

Though reports on the SAIC's criticisms have focused largely on the counterfeiting issues (and possibly implications for Alibaba's record-setting IPO), there is indication that government concern about counterfeiting is just one small part of a bigger push to assert greater regulatory control over online commerce. As previously mentioned, the SAIC white paper pointed to several non-IP problems it had with Alibaba's platforms. In fact, one of the leading complaints in the white paper related to the persistence of unregistered and unlicensed enterprises selling on Alibaba's marketplaces, as well as businesses using fake names and engaging in unauthorised activities. These concerns implicate not just the government's ability to protect intellectual property but also its broader interests in regulating e-commerce.

"These issues concern matters such as taxation, control, awareness of who the sellers are, and traceability," says one Beijing-based observer.

The white paper may be considered another step in the government's attempts to impose stronger e-commerce regulations. In March, the SAIC implemented its "New Measures for the Administration of Online Trading", which sought to increase consumer protections. In October, the SAIC and the Ministry of Industry and Information Technology issued its "Opinions on Reinforcing Collaboration on Supervision of Domestic Online Trading Websites and Active Promotion of the Development of E-Commerce", which further highlighted the need to regulate the e-commerce space. And earlier this month, China Daily reported that the National People's Congress will be submitting a draft of the country's first e-commerce law soon.

A good sign?

Though businesses are often sceptical of increasing government regulation especially on the famously freewheeling internet, the upcoming changes may actually be welcomed by brand owners. Some of the problems that hamper online enforcement, such as the difficulty in tracking infringers and the relative ease with which sellers can take on new online identities, may be addressed in this move, even if the expected changes do not necessarily prioritise IP enforcement. Though much will depend on the details of any new law and regulation that comes out, as well as the actual implementation, Alibaba's troubles may potentially be a boon for brand enforcement.

more from across site and ros bottom lb

More from across our site

Abion said the appointment of Silvia Asioli and the launch of its Milan office will expand its market position in southern Europe
UK firms who have hired litigation and transactional lawyers reveal how they work together and the lessons have they learned
Jonah Mitchell tells us why he would have liked to have tried his hand at being a firefighter or chef
Noemi Parrotta, chair of the European subcommittee within INTA’s International Amicus Committee, explains why we might not have heard the last of the morality debate
Counsel say the USPTO's examples of AI patentability should make their lives easier and help point clients in the right direction
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Ehsun Forghany says he was impressed by the firm's focus on fashion and IP as well as the expertise of chairman Anthony Lupo
Counsel at medical device companies say the unitary patent, AI and terminal disclaimers are major areas of concern
The LMG Life Sciences Awards is thrilled to present the shortlist for the 2024 Ameicas Awards
Daniel Wise at Carpmaels & Ransford explains how he helped secure the first UPC revocation ruling on behalf of Sanofi and Regeneron against Amgen
Gift this article